at that juncture the possible balance must be identified between the one hand boosting the research and rapid development of new medical largely derived from private research forwhih
At that juncture, the best possible balance must be identified between, on the one hand, boosting the research into and rapid development of new medical products largely derived from private sector research, for which intellectual property rights nowadays provide a key form of incentive, and, on the other hand, fairness in terms of providing access to the products developed from this research.
At that juncture, the possible balance must be identified between, the one hand, boosting the research and rapid development of new medical largely derived from private research, for which intellectual property rights nowadays a key form of incentive, and, on the other hand, in terms of providing to the products developed from this